Both in Pharmaceuticals
Werewolf Therapeutics vs Grace Therapeutics
Over the past year HOWL returned −58.4% and GRCE returned −29.0%; their daily moves had a correlation of 0.11.
HOWL −58.4% GRCE −29.0%Growth of $1, one year, split-adjusted
| Metric | HOWL | GRCE |
|---|---|---|
| Price | $0.9100 | $2.11 |
| Market cap | $44.2M | $44.4M |
| Today | −2.15% | −0.47% |
| 1 month | −3.5% | −0.5% |
| 6 months | +14.2% | −51.6% |
| Year to date | +43.6% | −39.0% |
| 1 year | −56.0% | −31.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | 17.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.1× | — |
| Net cash | $22.0M | $13.8M |
| Dividend yield | — | — |
| Volatility (60d) | 176.7% | 33.5% |
| Short % of float | 4.7% | 11.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).